The World Health Organization (WHO) published criteria for describing the response of metastatic bone cancer to therapy.
Imaging Study (X-Ray or Scan) |
Response |
complete disappearance of all lesions for >= 4 weeks |
complete |
partial decrease in size of lytic lesions for >= 4 weeks |
partial |
recalcification of lytic lesions for >= 4 weeks |
partial |
decreased density for blastic lesions for >= 4 weeks |
partial |
no change in size, number or appearance of bone lesions for >= 8 weeks |
no change (stable disease) |
increase in size of lesions |
progressive |
appearance of new lesions |
progressive |
where:
• The patient should be evaluated for several weeks after therapy prior to classification because of the relative slow response of bone lesions.
• Caution should be used in interpreting lesions with compression and fracture.
Specialty: Hematology Oncology, Surgery, general
ICD-10: ,